17th International Congress on Infectious Diseases

<strong>17th</strong> INTERNATIONAL CONGRESS ON INFECTIOUS DISEASES
Poster Presentations ~ Saturday, March 5, 2016
43.086 Novel cysteine desulphurase interacting
protein Isd11 from Leishmania donovani:
Identification and the role in Fe-S cluster
biogenesis
A. Zaidi, V. Ali
Patna (India)
Tuberculosis and Other Mycobacterial Infections
43.087 Association between BCG scars and risk of
tuberculosis transmission among household
contacts of active tuberculosis patients
M. Ali 1 , G. Velásquez 2 , M. Murray 2
1
New York, NY (USA), 2 Boston, MA (USA)
43.088 Trends of tuberculosis cases in Ondo state,
southern Nigeria; 2011–2014
M. O. Anyanwu 1 , S. Akingbesote 2 ,
O. Ajumobi 3 , A. Olayinka 3 , B. Adedokun 1 ,
V. Adelusi 2
1
Ibadan (Nigeria), 2 Akure (Nigeria),
3
Abuja (Nigeria)
43.089 Predictors of adherence to isoniazid
preventive therapy in HIV patients in
Ethiopia: A prospective cohort study
H. T. Ayele, M. S. V. Mourik, M. Bonten
Utrecht (Netherlands),
43.090 Seventeen years of drug-resistant tuberculosis
in Argentinian children
G. Berberian, S. Gonzalez, V. Reijtman,
N. Miño, L. Casimir, C. Sarkis,
D. Mecicovsky, M. T. Rosanova
Buenos Aires (Argentina)
43.091 Early cardiac safety of the 9-11 month Short
course regimen for MDR-TB treatment
C. E. Berry 1 , J. McMahon 2 , B.-T. Nyang’wa 1 ,
J. Archer 1 , A. Ronnachit 3 , A. Khamraev 3 ,
Z. Tigay 3 , P. du Cros 1
1
London (United Kingdom), 2 Melbourne
(Australia), 3 Nukus (Uzbekistan)
43.092 Detection of Mycobacterium leprae in tissue
sections using auramine O fluorescent stain
versus modified fite-faraco: A comparative
study
K. Bhardwaj, S. Ghate, R. Dhurat
Mumbai (India)
43.093 Curvilinear scars indicator of Lucio’s
phenomenon in leprosy
K. Bhardwaj, R. Dhurat, S. Ghate,
A. Dandale
Mumbai (India)
43.094 New antibacterial agents targeting
mycobacterial the ATP synthase
S. K. Bhola, I. A. Khan
Jammu (India))
43.095 Clinical profile and evaluation of diagnostic
tests in culture positive childhood
tuberculosis
D. Boddu, V. P. Vergese, J. Sarojini
Vellore (India)
43.096 Pharmacists contributing to the WHO Stop
TB theme: “Find, Treat, Cure Everyone”
A. Bompelli 1 , M. Gharat 2 , S. Prasad 3
1
Hanamkonda (India), 2 Mumbai (India),
3
Gurgaon (India)
43.097 Prevalence, risk factors and clinical
outcomes of Xpert MTB/RIF identified
rifampicin-resistant tuberculosis in Bukavu,
Democratic Republic of the Congo
A. Bulabula 1 , A. B. Shindano 2 , J. B. Nachega 3
1
Cape Town (South Africa), 2 Bukavu
(Democratic Republic of Congo), 3 Pittsburgh,
PA (USA)
43.098 Hospital based prospective observational
case study to evaluate the prevalance of
diabetes mellitus among tuberculosis patients
in a tertiary care hospital, in India
T. K. Charkha, S. Narreddy
Hyderabad (India)
43.099 Role of PCR for diagnosing male genital
tuberculosis
K. Chawla, A. Chawla, P. Hegde
Manipal (India)
43.100 Intranasal delivery of antituberculosis agents
in a murine tuberculosis model
C. Shoen, M. Cynamon
Syracuse, NY (USA)
43.101 Real-time PCR of whole blood specimens
transported in PrimeStore MTM ® to detect
and monitor MTB bacteremia
L. T. Daum 1 , R. Schuman 2 , C. Sei 2 , N. Rikhi 2 ,
A. Mesadieu 2 , F. Gerald 2
1
San Antonio, TX (USA), 2 Gaithersburg, MD
(USA)
43.102 GeneXpert detection of Mycobacterium
tuberculosis from sputum collected and
transported in a molecular transport medium
L. T. Daum 1 , P. Fourie 2 , R. Peters 2 ,
J. Rodriguez 1 , S. Worthy 1 , M. Khubbar 3 ,
S. Bhattacharyya 3 , M. Gradus 3 , C. Helm 1 ,
G. Fischer 1
1
San Antonio, TX (USA), 2 Pretoria (South
Africa), 3 Milwaukee, WI (USA)
SATURDAY • March 5, 2016
#<strong>17th</strong>ICID FINAL PROGRAM ~ 83